Sage Therapeutics Email & Phone number of top level executives

Company Icon

Sage Therapeutics

Biotechnology

Sage Therapeutics is a biopharmaceutical company located in Cambridge, Massachusetts, United States. The company focuses on the development and commercialization of novel medicines for central nervous system (CNS) disorders. Sage's pipeline includes potential treatments for various CNS conditions, including major depressive disorder, postpartum depression, Parkinson's disease, and essential tremor. The company's lead product, ZULRESSO™ (brexanolone) injection, is an FDA-approved treatment for postpartum depression. Sage is committed to advancing drug discovery and development to help treat a range of CNS disorders that have a significant impact on patients' lives.